Valor202020212022202320242025TTMGastos comerciales, generales y administrativos130.16 M129.76 M144.87 M148.88 M162.99 M177.4 M177.4 MInvestigación y desarrollo———————Beneficio operativo550.84 M314.81 M431.69 M439.9 M-724.65 M-893.54 M-890.09 MTotal de ingresos no operativos———67 M67 M——Gastos por intereses, netos de intereses capitalizados469.54 M440.09 M467.56 M574.11 M602.84 M612.25 M612.25 MIngresos no operativos, una vez deducidos los gastos por intereses———-507.11 M-535.84 M——Ingresos/gastos extraordinarios———————Beneficio antes de impuestos82.42 M-157.41 M-94.14 M-115.58 M-8 M204.32 M204.32 MParticipación en los beneficios1.83 M4.97 M28.5 M13.63 M1.56 M4.47 M-29.04 MImpuestos-96.53 M4.83 M-16.93 M-9.54 M-37.77 M-14.15 M-14.15 MParticipación minoritaria2.04 M7.55 M6.52 M10.68 M7.2 M10.14 M10.14 MOtros ingresos/gastos después de impuestos779 K-26.4 M-52.49 M44.5 M-25.76 M-11.66 M-11.66 MBeneficio neto antes de actividades interrumpidas441.19 M56.56 M-40.93 M-30.3 M88.35 M261.52 M261.52 MOperaciones suspendidas0——————Beneficio neto441.19 M56.56 M-40.93 M-30.3 M88.35 M261.52 M261.52 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas439.15 M49.01 M-47.45 M-40.97 M81.15 M251.38 M251.38 MBeneficio básico por acción1.180.13-0.12-0.10.20.550.55Beneficio por acción diluido1.170.13-0.12-0.10.190.540.54Número medio de acciones ordinarias373.37 M382.79 M373.37 M401.81 M411.77 M455.08 M1.8 BAcciones diluidas376.5 M386.3 M403.45 M405.67 M416.37 M462.62 M1.83 BEBITDA-1.07 B1.07 B1.13 B1.32 B1.3 B1.65 B905.89 MEBIT-2.22 B-162.38 M-94.14 M-115.58 M-8 M204.32 M204.32 MCosto de los ingresos1.96 B2.08 B2.3 B2.54 B4.25 B5.16 B5.16 BOtros costes de producción1.94 B2.09 B2.28 B2.56 B4.25 B5.16 B5.16 BAmortización y depreciación (flujo de caja)1.15 B1.23 B1.23 B1.44 B1.31 B1.44 B701.57 M
Ventas Inc
Ventas, Inc. is a real estate investment trust specializing in the ownership and management of research, medicine and healthcare facilities in the United States, Canada and the United Kingdom.
As of December 2019, the group's portfolio consisted of 1,200 properties divided among nursing homes, medical office buildings, rehabilitation and acute care centres, special care centres, laboratories and research centres and medical-surgical centres for a total value of nearly $25 billion.
As of 2019, it is a Fortune 1000 corporation.